Co-founder of Paradigm Steps Down as Managing Partner to Pursue Science
- Fred Ehrsam is transitioning from the role of Managing Partner to General Partner at Paradigm.
- Ehrsam has a longstanding interest in exploring the boundaries of biology, a passion shared by the crypto community.
- Matt Huang, co-founder and recent witness in Sam Bankman-Fried’s trial, will remain as Managing Partner.
A Passion for Science
Fred Ehrsam, a well-known name in the crypto community, has made the decision to shift his career focus. In a recent post on X (formerly known as Twitter), Ehrsam explained that his new role as General Partner at Paradigm would allow him to dedicate more time to his long-standing passion for science.
An Impressive Trajectory in Crypto
After co-founding Coinbase with Brian Armstrong, Ehrsam partnered with Matt Huang to launch Paradigm in 2018. The investment firm quickly gained prominence in the crypto world. Ehrsam has consistently believed that crypto will be one of the most transformative technologies in the coming decades.
The Fusion of Crypto and Science and the Future of Paradigm
Ehrsam’s interest in science is not new. He highlighted the crypto community’s historical interest in biology, referencing Hal Finney and cryonics, as well as recent support from Vitalik Buterin and Brian Armstrong for longevity research. This fusion of two worlds is not just a passing curiosity for Ehrsam; he has been investing in and supporting biological research for several years.
With Ehrsam stepping down from the role of Managing Partner, the investment firm will now be led by co-founder Matt Huang and Alana Palmedo, Director of Operations. It is worth noting that Huang recently testified in the controversial trial of Sam Bankman-Fried, former CEO of FTX, discussing Paradigm’s significant loss following investments in FTX.
